Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilizing Virtual Reality Analgesia (VRA) as a First Line Nonpharmacologic Analgesic Intervention on the Acute Rehabilitation Unit: A Pilot Study

NCT03894592 is registered in ClinicalTrials.gov with New York City Health and Hospitals Corporation as lead sponsor.

NCT NCT03894592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03894592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilizing Virtual Reality Analgesia (VRA) as a First Line Nonpharmacologic Analgesic Intervention on the Acute Rehabilitation Unit: A Pilot Study
Lead sponsor
New York City Health and Hospitals Corporation
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2019
Completion date
October 31, 2020
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, musculoskeletal pain, opioid use, trauma injury, virtual reality, virtual reality analgesia